Insights

Hofseth Biocare ASA

Euronext Oslo · LEI 5967007LIEEXZXGGEO44· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Revenue fell 0.9% year over year.
  • Operating loss of $11.5M in 2025.

Last 3 years

Revenue
$26.4M2024$26.1M2025
Operating income
-$10.8M2024-$11.5M2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
-44.2%
Net margin
-53.0%
Equity ratio
-19.2%

USD at NOK 9.73 per $1 (2026-11-20, ExchangeRate-API)

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.